+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Butterfly Needle Sets Market by Application and End User: Global Opportunity Analysis and Industry Forecast, 2020-2027

  • PDF Icon

    Report

  • 199 Pages
  • June 2020
  • Region: Global
  • Allied Market Research
  • ID: 5134086
The global butterfly needle blood collection set market was $166.60 million in 2019, and is expected to reach $320.02 million by 2027, registering a CAGR 8.20% from 2020 to 2027. A butterfly needle is a device used to provide access to superficial vein for drawing blood or for an IV injection. These needles are much easier to use and is less painful due to winged tubing structure that allows greater flexibility. In addition, butterfly needles, also known as a winged infusion set or a scalp vein set, are commonly used for babies, young children, and elderly to draw blood or to administer medication. The needles are short and straight with plastic wings attached for phlebotomists to hold during insertion and ease operation. In addition, winged-infusion blood collection needles are ideal for individuals with small or fragile veins. Further, the common butterfly needles, which are frequently used ranges from gauges, with 21 and 23 gauge (G) and the smallest gauge i.e., 25–27G, are being used primarily for pediatric patients.

The major factors that drive market growth are rise in the prevalence of chronic diseases globally such as cancer, intravenous therapy, cardiovascular diseases, and bleeding disorders. In addition, an increase in the prevalence of chronic diseases and need for managing long term medications and drug infusions are some of the other factors that boost the growth of the market. However, lack of product innovations and regulatory standards on butterfly needle usage and phlebotomists blood collection hamper market growth. Moreover, safety and convenience provided by the needles d treatment associated with butterfly needle offer opportunities for market growth during the forecast period.

The global butterfly needle blood collection set market is segmented on the basis of application, end user, and region. By application, the market is segmented into blood transfusion, venipuncture, IV rehydration, and delivery of medications. By end user, it is segmented into hospitals, blood bank, and others. Region wise, the market is categorized into North America, Europe, Asia-Pacific, and LAMEA. These regions are further analyzed on the basis of the respective countries.

KEY BENEFITS FOR STAKEHOLDERS
  • The market estimations in this report are based on high-end analysis of the key segments from 2019 to 2027.
  • Extensive analysis of the global butterfly needle blood collection set market, by application, helps in understanding various types of techniques of butterfly needles.
  • This report provides comprehensive analysis of factors that drive and restrict growth of the butterfly needle blood collection set market.
  • Porter’s Five Forces model provides an in-depth analysis of the bargaining power of buyers and suppliers, threats of new entrants, substitutes, and competition among the key market players.
  • Competitive intelligence highlights the business practices adopted by leading market players across various regions.

Key Market Segments

By application
  • Blood transfusion
  • Venipuncture
  • IV rehydration
  • Delivery of medications

By end user
  • Hospitals
  • Blood banks
  • Others

By Region
  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Rest of Europe
  • Asia-Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of Asia-Pacific
  • LAMEA
  • Brazil
  • Turkey
  • Venezuela
  • Saudi Arabia
  • Rest of LAMEA

List of key players profiled in the report
  • B. Braun Melsungen AG
  • Becton, Dickinson and Company
  • Nipro Corporation
  • Cardinal Health, Inc.
  • Medline Industries, Inc.
  • Terumo Corporation
  • Kawasumi Laboratories, Inc.
  • ISOMed
  • BioMatrix S.r.l

Table of Contents

Chapter 1: Introduction
1.1. Report Description
1.2. Key Benefits
1.3. Key Market Segments
1.4. Research Methodology
1.4.1. Primary Research
1.4.2. Secondary Research
1.4.3. Analyst Tools and Models
Chapter 2: Executive Summary
2.1. Key Findings of the Study:
2.2. CXO Perspective
Chapter 3: Market Overview
3.1. Key Findings
3.1.1. Top Investment Pockets
3.2. Porter’sFive Forces Analysis
3.3. Market Definition and Scope
3.3.1. Impact Analysis
3.3.2. Drivers
3.3.2.1. Rise in Prevalence of Chronic Diseases Globally
3.3.2.2. Precise and Easy Use of Butterfly Needles Set
3.3.2.3. Need for Managing Long Term Medication and Drug Infusion
3.3.3. Restraints
3.3.3.1. Lack of Product Innovation
3.3.3.2. Regulatory Standards
3.3.4. Opportunities
3.3.4.1. Safety and Convenience Associated With Butterfly Needles
Chapter 4: Butterfly Needle Blood Collection Set Market, by Application
4.1. Overview
4.1.1. Market Size and Forecast
4.2. Blood Transfusion
4.2.1. Key Market Trends, Growth Factors and Opportunities
4.2.2. Market Size and Forecast, by Region
4.2.3. Market Share Analysis, by Country
4.3. Venipuncture
4.3.1. Key Market Trends, Growth Factors and Opportunities
4.3.2. Market Size and Forecast, by Region
4.3.3. Market Share Analysis, by Country
4.4. Iv Rehydration
4.4.1. Key Market Trends, Growth Factors and Opportunities
4.4.2. Market Size and Forecast, by Region
4.4.3. Market Share Analysis, by Country
4.5. Delivery of Medications
4.5.1. Key Market Trends, Growth Factors and Opportunities
4.5.2. Market Size and Forecast, by Region
4.5.3. Market Share Analysis, by Country
Chapter 5: Butterfly Needle Blood Collection Set Market, by End-user
5.1. Overview
5.1.1. Market Size and Forecast
5.2. Hospital
5.2.1. Market Size and Forecast, by Region
5.2.2. Market Share Analysis, by Country
5.3. Blood Bank
5.3.1. Market Size and Forecast, Region
5.3.2. Market Share Analysis, by Country
5.4. Others
5.4.1. Market Size and Forecast, by Region
5.4.2. Market Share Analysis, by Country
Chapter 6: Butterfly Needle Blood Collection Set Market, by Region
6.1. Overview
6.1.1. Market Size and Forecast
6.2. North America
6.2.1. Key Market Trends and Opportunities
6.2.2. North America, by Average Selling Price
6.2.3. North America, by Market Share Analysis
6.2.4. North America Market Size and Forecast, by Country
6.2.5. North America Market Size and Forecast, by Application
6.2.6. North America Market Size and Forecast, by End-user
6.2.6.1. U. S.
6.2.6.1.1. U. S, by Market Share Analysis
6.2.6.1.2. U. S. Market Size and Forecast, by Application
6.2.6.1.3. U. S. Market Size and Forecast, by End-user
6.2.6.2. Canada
6.2.6.2.1. Canada, by Market Share Analysis
6.2.6.2.2. Canada Market Size and Forecast, by Application
6.2.6.2.3. Canada Market Size and Forecast, by End-user
6.2.6.3. Mexico
6.2.6.3.1. Mexico, by Market Share Analysis
6.2.6.3.2. Mexico Market Size and Forecast, by Application
6.2.6.3.3. Mexico Market Size and Forecast, by End-user
6.3. Europe
6.3.1. Key Market Trends and Opportunities
6.3.2. Europe, by Average Selling Price
6.3.3. Europe, by Market Share Analysis
6.3.4. Europe Market Size and Forecast, by Country
6.3.5. Europe Market Size and Forecast, by Application
6.3.6. Europe Market Size and Forecast, by End-user
6.3.6.1. Germany
6.3.6.1.1. Germany, by Market Share Analysis
6.3.6.1.2. Germany Market Size and Forecast, by Application
6.3.6.1.3. Germany Market Size and Forecast, by End-user
6.3.6.2. UK
6.3.6.2.1. Uk, by Market Share Analysis
6.3.6.2.2. UK Market Size and Forecast, by Application
6.3.6.2.3. UK Market Size and Forecast, by End-user
6.3.6.3. France
6.3.6.3.1. France, by Market Share Analysis
6.3.6.3.2. France Market Size and Forecast, by Application
6.3.6.3.3. France Market Size and Forecast, by End-user
6.3.6.4. Italy
6.3.6.4.1. Italy, by Market Share Analysis
6.3.6.4.2. Italy Market Size and Forecast, by Application
6.3.6.4.3. Italy Market Size and Forecast, by End-user
6.3.6.5. Spain
6.3.6.5.1. Spain, by Market Share Analysis
6.3.6.5.2. Spain Market Size and Forecast, by Application
6.3.6.5.3. Spain Market Size and Forecast, by End-user
6.3.6.6. Rest of Europe
6.3.6.6.1. Rest of Europe, by Market Share Analysis
6.3.6.6.2. Rest of Europe Market Size and Forecast, by Application
6.3.6.6.3. Rest of Europe Market Size and Forecast, by End-user
6.4. Asia-Pacific
6.4.1. Key Market Trends and Opportunities
6.4.2. Asia-Pacific, by Average Selling Price
6.4.3. Asia-Pacific, by Market Selling Price
6.4.4. Asia-Pacific Market Size and Forecast, by Country
6.4.5. Asia-Pacific Market Size and Forecast, by Application
6.4.6. Asia-Pacific Market Size and Forecast, by End-user
6.4.6.1. India
6.4.6.1.1. India, by Market Share Analysis
6.4.6.1.2. India Market Size and Forecast, by Application
6.4.6.1.3. India Market Size and Forecast, by End-user
6.4.6.2. China
6.4.6.2.1. China, by Market Share Analysis
6.4.6.2.2. China Market Size and Forecast, by Application
6.4.6.2.3. China Market Size and Forecast, by End-user
6.4.6.3. Japan
6.4.6.3.1. Japan, by Market Share Analysis
6.4.6.3.2. Japan Market Size and Forecast, by Application
6.4.6.3.3. Japan Market Size and Forecast, by End-user
6.4.6.4. Australia
6.4.6.4.1. Australia, by Market Share Analysis
6.4.6.4.2. Australia Market Size and Forecast, by Application
6.4.6.4.3. Australia Market Size and Forecast, by End-user
6.4.6.5. South Korea
6.4.6.5.1. South Korea, by Market Share Analysis
6.4.6.5.2. South Korea Market Size and Forecast, by Application
6.4.6.5.3. South Korea Market Size and Forecast, by End-user
6.4.6.6. Rest of Asia-Pacific
6.4.6.6.1. Rest of Asia-Pacific, by Market Share Analysis
6.4.6.6.2. Rest of Asia-Pacific Market Size and Forecast, by Application
6.4.6.6.3. Rest of Asia-Pacific Market Size and Forecast, by End-user
6.5. LAMEA
6.5.1. Key Market Trends and Opportunities
6.5.2. Lamea, by Average Selling Price
6.5.3. Lamea, by Market Share Analysis
6.5.4. LAMEA Market Size and Forecast, by Country
6.5.5. LAMEA Market Size and Forecast, by Application
6.5.6. LAMEA Market Size and Forecast, by End-user
6.5.6.1. Brazil
6.5.6.1.1. Brazil, by Market Share Analysis
6.5.6.1.2. Brazil Market Size and Forecast, by Application
6.5.6.1.3. Brazil Market Size and Forecast, by End-user
6.5.6.2. Saudi Arabia
6.5.6.2.1. Saudi Arabia, by Market Share Analysis
6.5.6.2.2. Saudi Arabia Market Size and Forecast, by Application
6.5.6.2.3. Saudi Arabia Market Size and Forecast, by End-user
6.5.6.3. South Africa
6.5.6.3.1. South Africa, by Market Share Analysis
6.5.6.3.2. South Africa Market Size and Forecast, by Application
6.5.6.3.3. South Africa Market Size and Forecast, by End-user
6.5.6.4. Rest of LAMEA
6.5.6.4.1. Rest of Lamea, by Market Share Analysis
6.5.6.4.2. Rest of LAMEA Market Size and Forecast, by Application
6.5.6.4.3. Rest of LAMEA Market Size and Forecast, by End-user
Chapter 7: Comapany Profiles
7.1. B. Braun Melsungen AG
7.1.1. Company Overview
7.1.2. Company Snapshot
7.1.3. Operating Business Segments
7.1.4. Product Portfolio
7.1.5. Business Performance
7.2. Becton, Dickinson and Company
7.2.1. Company Overview
7.2.2. Company Snapshot
7.2.3. Operating Business Segments
7.2.4. Product Portfolio
7.2.5. Business Performance
7.3. Nipro Corporation (Nipro Medical Corporation)
7.3.1. Company Overview
7.3.2. Operating Business Segments
7.3.3. Product Portfolio
7.3.4. Business Performance
7.4. Cardinal Health Inc.
7.4.1. Company Overview
7.4.2. Company Snapshot
7.4.3. Operating Business Segments
7.4.4. Product Portfolio
7.4.5. Business Performance
7.5. Medline Industries, Inc.
7.5.1. Company Overview
7.5.2. Company Snapshot
7.5.3. Operating Business Segments
7.5.4. Product Portfolio
7.6. Terumo Corporation (Terumo Medical Corporation)
7.6.1. Company Overview
7.6.2. Company Snapshot
7.6.3. Operating Business Segments
7.6.4. Product Portfolio
7.6.5. Business Performance
7.7. Kawasumi Laboratories, Inc. (Kawasumi Laboratories America, Inc.)
7.7.1. Company Overview
7.7.2. Company Snapshot
7.7.3. Operating Business Segments
7.7.4. Product Portfolio
7.7.5. Business Performance
7.8. Isomed
7.8.1. Company Overview
7.8.2. Company Snapshot
7.8.3. Operating Business Segments
7.8.4. Product Portfolio
7.9. Biomatrix S. R. L.
7.9.1. Company Overview
7.9.2. Company Snapshot
7.9.3. Operating Business Segments
7.9.4. Product Portfolio
7.10. Smith’S Group plc
7.10.1. Company Overview
7.10.2. Company Snapshot
7.10.3. Operating Business Segments
7.10.4. Product Portfolio
7.10.5. Business Performance

Companies Mentioned

  • Braun Melsungen AG
  • Becton
  • Dickinson and Company
  • Nipro Corporation
  • Cardinal Health Inc
  • Medline Industries Inc
  • Terumo Corporation
  • Kawasumi Laboratories Inc
  • ISOMed
  • BioMatrix Srl

Methodology

The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.

They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.

They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:

  • Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic news articles and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast

Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.

Loading
LOADING...